Literature DB >> 17163805

Medical management of gastroesophageal reflux disease.

Dawn D Ferguson1, Kenneth R DeVault.   

Abstract

Gastroesophageal reflux disease is a common worldwide disorder. Most patients have typical symptoms of heartburn, regurgitation and exacerbation of symptoms with large meal volumes, fatty meals, recumbency or bending forward. Patients who show typical symptoms for under 10 years may be treated empirically with lifestyle and dietary modifications plus acid-suppressing medications. The recent decrease in cost, established safety and wide availability of proton pump inhibitors make them the best choice for monotherapy. Other medical therapies include antacids, H(2) receptor antagonists and prokinetic agents. Patients who have alarm symptoms or long-standing symptoms should have an esophagoscopy to evaluate for complications of reflux. Patients who do not respond to therapy should have a test to confirm the diagnosis of gastroesophageal reflux disease.

Entities:  

Mesh:

Year:  2007        PMID: 17163805     DOI: 10.1517/14656566.8.1.39

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN: 1465-6566            Impact factor:   3.889


  7 in total

Review 1.  Proton pump inhibitors: an update of their clinical use and pharmacokinetics.

Authors:  Shaojun Shi; Ulrich Klotz
Journal:  Eur J Clin Pharmacol       Date:  2008-08-05       Impact factor: 2.953

2.  The effect of lansoprazole, an OCT inhibitor, on metformin pharmacokinetics in healthy subjects.

Authors:  Yi Ding; YanYan Jia; Ying Song; ChengTao Lu; YuWen Li; MinChun Chen; MingMing Wang; AiDong Wen
Journal:  Eur J Clin Pharmacol       Date:  2013-10-30       Impact factor: 2.953

3.  Acid peptic diseases: pharmacological approach to treatment.

Authors:  Alex Mejia; Walter K Kraft
Journal:  Expert Rev Clin Pharmacol       Date:  2009-05       Impact factor: 5.045

Review 4.  Esomeprazole: a review of its use in the management of gastric acid-related diseases in adults.

Authors:  Kate McKeage; Stephanie K A Blick; Jamie D Croxtall; Katherine A Lyseng-Williamson; Gillian M Keating
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 5.  Rabeprazole: a review of its use in the management of gastric acid-related diseases in adults.

Authors:  Claudine M Baldwin; Susan J Keam
Journal:  Drugs       Date:  2009-07-09       Impact factor: 9.546

6.  Proton pump inhibitors do not impair the effectiveness of metformin in patients with diabetes.

Authors:  James Flory; Kevin Haynes; Charles E Leonard; Sean Hennessy
Journal:  Br J Clin Pharmacol       Date:  2015-02       Impact factor: 4.335

7.  Proton pump inhibitors inhibit metformin uptake by organic cation transporters (OCTs).

Authors:  Anne T Nies; Ute Hofmann; Claudia Resch; Elke Schaeffeler; Maria Rius; Matthias Schwab
Journal:  PLoS One       Date:  2011-07-14       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.